APA

Pfreundschuh M. G., Schoppe W. D., Fuchs R., Pflüger K. H., Loeffler M. & Diehl V. (19880203). Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group. : Cancer treatment reports.

Chicago

Pfreundschuh M G, Schoppe W D, Fuchs R, Pflüger K H, Loeffler M and Diehl V. 19880203. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group. : Cancer treatment reports.

Harvard

Pfreundschuh M. G., Schoppe W. D., Fuchs R., Pflüger K. H., Loeffler M. and Diehl V. (19880203). Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group. : Cancer treatment reports.

MLA

Pfreundschuh M G, Schoppe W D, Fuchs R, Pflüger K H, Loeffler M and Diehl V. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group. : Cancer treatment reports. 19880203.